ZAP Surgical is a leading brand dedicated to revolutionizing the field of stereotactic radiosurgery (SRS) with their innovative ZAP-X platform. With millions of brain tumor patients worldwide in need of SRS treatment, ZAP Surgical aims to make world-class SRS accessible to those who currently lack access. Their core values of respect, patient-focus, startup mindset, leading by example, and hitting their marks drive their commitment to delivering the best possible outcomes for patients.

ZAP Surgical was founded by Dr. John R. Adler, Jr., a renowned pioneer in stereotactic radiosurgery and an esteemed professor at Stanford University.

The ZAP-X platform, developed by ZAP's team of clinical and industry experts, represents the next frontier in radiosurgery for the brain. This advanced surgical robot addresses the limitations of previous systems, allowing for potentially life-saving SRS to be delivered to more people in more places. With the clearance received from the U.

S. FDA, Japan Shonin, and E. U.

CE, ZAP-X is poised to redefine the field of radiosurgery. Their commitment to innovation and their team's expertise make ZAP Surgical a trusted leader in the industry